Martin Krkoska
Brno, JM 65653, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Engineered Peptide Coacervates Enable Efficient Intracellular Delivery of the MYC Inhibitor omoMYC.
Journal: Molecular pharmaceutics
Published: April 30, 2025
Heterogeneity of glucose metabolism and uptake identifies distinct cancer cell and cancer stem cell phenotypes.
Journal: Cellular & molecular biology letters
Published: April 01, 2025
Inhibition of Chk1 stimulates cytotoxic action of platinum-based drugs and TRAIL combination in human prostate cancer cells.
Journal: Biological chemistry
Published: January 13, 2023
Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma.
Journal: Pharmacological reports : PR
Published: August 27, 2021
Deregulation of signaling pathways controlling cell survival and proliferation in cancer cells alters induction of cytochrome P450 family 1 enzymes.
Journal: Toxicology
Published: December 30, 2020
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: September 20, 2019
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.
Journal: Neoplasia (New York, N.Y.)
Published: June 08, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026